174 related articles for article (PubMed ID: 10779234)
1. Recent advances in colorectal chemotherapy: oral fluorinated pyrimidines, oxaliplatin and irinotecan.
Pazdur R
J Gastroenterol; 2000; 35 Suppl 12():131. PubMed ID: 10779234
[No Abstract] [Full Text] [Related]
2. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
[No Abstract] [Full Text] [Related]
3. [Initial results of randomized studies of metastatic colorectal carcinoma urge careful and controlled use of CPT-11].
Klautke G; Fietkau R
Strahlenther Onkol; 2002 Mar; 178(3):163-4. PubMed ID: 11962194
[No Abstract] [Full Text] [Related]
4. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
Allegra C; George T; Yothers G
J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834
[No Abstract] [Full Text] [Related]
5. [Standard chemotherapy for colonic neoplasms].
Hyodo I
Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):283-8. PubMed ID: 17370594
[No Abstract] [Full Text] [Related]
6. Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
Punt CJ
Ann Oncol; 2005 Jun; 16(6):845-6. PubMed ID: 15890668
[No Abstract] [Full Text] [Related]
7. Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer.
Goldberg RM; Gill S
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S57-64. PubMed ID: 15309516
[TBL] [Abstract][Full Text] [Related]
8. Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.
Fisher MD
Clin Colorectal Cancer; 2001 Aug; 1(2):82-4. PubMed ID: 12445364
[No Abstract] [Full Text] [Related]
9. [Chemotherapy of colorectal carcinoma].
Lutz MP; Adler G
Internist (Berl); 2001 Dec; 42(12):1567-8, 1571-6, 1578-82. PubMed ID: 11793596
[No Abstract] [Full Text] [Related]
10. Roles of infusional high-dose 5-fluorouracil with leucovorin in advanced colorectal cancer.
Liu JH
Clin Colorectal Cancer; 2004 Sep; 4(3):204-5. PubMed ID: 15377404
[No Abstract] [Full Text] [Related]
11. Current perspectives in the treatment of metastatic colorectal cancer.
Köhne CH; Folprecht G
Ann Oncol; 2004; 15 Suppl 4():iv43-53. PubMed ID: 15477334
[No Abstract] [Full Text] [Related]
12. Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
Garant A; Des Groseilliers S; Martin L; Ferland É; Vuong T
Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):497-8. PubMed ID: 21576010
[No Abstract] [Full Text] [Related]
13. Strategic options on behalf of patients with metastatic colorectal cancer: mass tumor murder versus serial tumor killing.
Goldberg RM
Onkologie; 2010; 33(6):291-2. PubMed ID: 20523091
[No Abstract] [Full Text] [Related]
14. Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line.
Grothey A; Sargent D
J Clin Oncol; 2005 Dec; 23(36):9441-2. PubMed ID: 16361649
[No Abstract] [Full Text] [Related]
15. (Neo-)adjuvant treatments in colorectal cancer.
Arnold D; Schmoll HJ
Ann Oncol; 2005; 16 Suppl 2():ii133-40. PubMed ID: 15958444
[No Abstract] [Full Text] [Related]
16. Developments in combination chemotherapy for colorectal cancer.
Goetz MP; Grothey A
Expert Rev Anticancer Ther; 2004 Aug; 4(4):627-37. PubMed ID: 15270666
[TBL] [Abstract][Full Text] [Related]
17. [Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].
Motomura S
Nihon Rinsho; 2003 Sep; 61 Suppl 7():360-3. PubMed ID: 14574913
[No Abstract] [Full Text] [Related]
18. Current and ongoing trials with irinotecan in the United States.
Fuchs CS
Semin Oncol; 2003 Aug; 30(4 Suppl 12):9-17. PubMed ID: 14508722
[No Abstract] [Full Text] [Related]
19. Another NICE mess.
Lancet Oncol; 2002 Jul; 3(7):385. PubMed ID: 12142149
[No Abstract] [Full Text] [Related]
20. Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials.
Blanke CD; Bot BM; Thomas DM; Bleyer A; Kohne CH; Seymour MT; de Gramont A; Goldberg RM; Sargent DJ
J Clin Oncol; 2011 Jul; 29(20):2781-6. PubMed ID: 21646604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
